Jaime Wheeler

CEO

Jaime brings more than 25 years of medical device and pharmaceutical leadership, deep clinical research expertise across Cardiology and Structural Heart, and a track record of guiding innovative technologies to market. She has managed multiple divisions and regions, including an expatriate assignment in Tokyo, Japan, and served as clinical lead on multiple successful mergers and acquisitions during her career.

She spent 12 years at Edwards Lifesciences, most recently as Senior Vice President of Global Clinical Affairs for the Transcatheter Heart Valve business unit, where she played a pivotal role in advancing the clinical evidence that shapes transcatheter structural heart care today — most notably the PARTNER trial series. Beyond her research leadership, she is a strong advocate for patient access, representation, and health equity, and has held active roles in industry and community leadership.